Mar 16, 2005This article was originally published by RFID Update.
March 16, 2005—A three-month pharmaceutical tagging pilot has completed in the U.K. with successful results, according to Aegate, the lead technology provider of the initiative. The pilot, in which 180,000 bottles of medicine were tracked, was meant to test whether RFID tagging could significantly cut down on pharmaceutical counterfeiting. Some estimates put the annual cost of counterfeiting to the pharmaceutical industry as high as $68 billion. Owing to its success, the tagging initiative, dubbed Authentication at the Point of Dispensing, will be expanded throughout the U.K., possibly within the next 12 months.
More at vnunet.com
